SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001683168-24-001829
Filing Date
2024-03-28
Accepted
2024-03-28 17:27:04
Documents
1
Period of Report
2024-04-30

Document Format Files

Seq Description Document Type Size
1 FORM PRE14A cns_pre14a.htm PRE 14A 516742
  Complete submission text file 0001683168-24-001829.txt   517819
Mailing Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027
Business Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027 1-800-946-9185
CNS Pharmaceuticals, Inc. (Filer) CIK: 0001729427 (see all company filings)

IRS No.: 822318545 | State of Incorp.: NV | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-39126 | Film No.: 24800620
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)